Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation

Genes and Development

Volumn 14, Issue 2, 2000, Pages 232-244

  Kieslinger, Matthias ^a   Woldman, Irina ^b   Moriggl, Richard ^c   Hofmann, Johannes ^a   Marine, Jean Christophe ^c   Ihle, James N ^c   Beug, Hartmut ^a   Decker, Thomas ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b Vienna Biocenter   (Austria)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Apoptosis; Hematopoiesis; Myeloid differentiation; Stat5

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; PROTEIN BCL 2; STAT PROTEIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHICKEN; CONTROLLED STUDY; HEMATOPOIESIS; MOUSE; MYELOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEM CELL;

ALLELES; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELLS, CULTURED; CHICKENS; DNA-BINDING PROTEINS; HEMATOPOIESIS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MILK PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

ANIMALIA; GALLUS GALLUS;

EID: 0034650805     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Azam, M., H. Erdjument-Bromage, B.L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J.N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 14: 1402-1411.
2. Barahmand-pour, F., A. Meinke, A. Eilers, F. Gouilleux, B. Groner, and T Decker. 1995. Colony-stimulating factors and interferon-gamma activate a protein related to MGF-Stat 5 to cause formation of the differentiation-induced factors in myeloid cells. FEBS Letters360: 29-33.
3. Bedi, A. and S.J. Sharkis. 1995. Mechanisms of cell commitment in myeloid cell differentiation. Curr. Opin. Hematol. 2: 12-21.
4. Beug, H., A. Leutz, P. Kahn, and T. Graf. 1984. Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the nonpermissive temperature. Cell 39: 579-588.
5. Beug, H., P.A. Blundell, and T. Graf. 1987. Reversibility of differentiation and proliferative capacity in avian myelomonocytic cells transformed by tsE26 leukemia virus. Genes & Dev. 1: 277-286.
6. Catlett-Falcone, R., T.H. Landowski, M.M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J.L. Fernandez-Luna, G. Nunẽz et al. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115.
7. Chretien, S., P. Varlet, F. Verdier, S. Gobert, J.P. Cartron, S. Gisselbrecht, P. Mayeux, and C. Lacombe. 1996. Erythropoietin-induced erythroid differentiation of the human erythro-leukemia cell line TF-1 correlates with impaired STATS activation. EMBO J. 15: 4174-4181.
8. Daems, W.T. and H.K. Koerten. 1978. The effects of various stimuli on the cellular composition of peritoneal exudates in the mouse. Cell Tissue Res. 190: 47-60.
9. Damen, J.E., H. Wakao, A. Miyajima, J. Krosl, R.K. Humphries, R.L. Cutler, and G. Krystal. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14: 5557-5568.
10. Darnell, J.E., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
11. Decker, T., P. Kovarik, and A. Meinke. 1997. Gas elements: A few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine, Res. 17: 121-134.
12. Dexter, T.M. and E. Spooncer. 1987. Growth and differentiation in the hemopoietic system. Annu. Rev. Cell Biol. 3: 423-441.
13. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
14. Dumon, S., S.C. Santos, F. Debierre-Grockiego, V. Gouilleux-Gruart, L. Cocault, C. Boucheron, P. Mollat, S. Gisselbrecht, and F. Gouilleux. 1999. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18: 4191-4199.
15. Eilers, A., M. Baccarini, F. Horn, R.A. Hipskind, C. Schindler, and T. Decker. 1994. A factor induced by differentiation signals in cells of macrophage lineage binds to the gamma interferon activation site. Mol. Cell. Biol. 14: 1364-1373.
16. Feldman, G.M., L.A. Rosenthal, X. Liu, M.P. Hayes, A. Wynshaw-Boris, W.J. Leonard, L. Hennighausen, and D.S. Finbloom. 1997. Stat5a-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 1768-1776.
17. Frampton, J., T. Ramqvist, and T. Graf. 1996. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes & Dev. 10: 2720-2731.
18. Fujii, H., Y. Nakagawa, U. Schindler, A. Kawahara, H. Mori, F. Gouilleux, B. Groner, J.N. Ihle, Y. Minami, T. Miyazaki et al. 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. 92: 5482-5486.
19. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5: 449-460.
20. Fukada, T., T. Ohtani, Y. Yoshida, T. Shirogane, K. Nishida, K. Nakajima, M. Hibi, and T. Hirano. 1998. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 17: 6670-6677.
21. Grillot, D.A., M. Gonzalez-Garcia, D. Ekhterae, L. Duan, N. Inohara, S. Ohta, M.F. Seldin, and G. Nuñez. 1997. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158: 4750-4757.
22. Ihle, J.N. 1992. Interleukin-3 and hematopoiesis. Chem. Immunol. 51: 65-106.
23. _. 1995. Cytokine receptor signalling. Nature 377:591-594.
24. Lagasse, E. and I.L. Weissman. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031.
25. Leonard, W.J. and J.J. O'Shea. 1998. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16: 293-322.
26. Lieschke, G.J., E. Stanley, D. Grail, G. Hodgson, V. Sinickas, J.A. Gall, R.A. Sinclair, and A.R. Dunn. 1994. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84: 27-35.
27. Matsumura, I., J. Ishikawa, K. Nakajima, K. Oritani, Y. Tomiyama, J. Miyagawa, T. Kato, H. Miyazaki, Y. Matsuzawa, and Y. Kanakura. 1997. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17: 2933-2943.
28. Mellitzer, G., O. Wessely, T. Decker, A. Eilers, M.J. Hayman, and H. Beug. 1996. Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation. Proc. Natl. Acad. Sci. 93: 9600-9605.
29. Moriggl, R., V. Gouilleux Gruart, R. Jahne, S. Berchtold, C. Gartmann, X. Liu, L. Hennighausen, A. Sotiropoulos, B. Groner, and F. Gouilleux. 1996. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell Biol. 16: 5691-5700.
30. Moriggl, R., D.J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M.Y. Sangster, K.D. Bunting et al. 1999. Stat5 is required for IL-2 induced cell cycle progression of peripheral T cells. Immunity 10: 249-259.
31. Morrison, S.J., N.M. Shah, and D.J. Anderson. 1997. Regulatory mechanisms in stem cell biology. Cell 88: 287-298.
32. Mui, A. 1999. The role of Stats in proliferation, differentiation and apoptosis. Cell Mol. Life Sci. 55: 1547-1558.
33. Mui, A.L., H. Wakao, A.M. O'Farrell, N. Harada, and A. Miyajima. 1995. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologs. EMBO J. 14: 1166-1175.
34. Mui, A.L.-F., H. Wakao, T. Kinoshita, T. Kitamura, and A. Miyajima. 1996. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat: Role of Stat5 in proliferation. EMBO J. 15: 2425-2431.
35. Nosaka, T., T. Kawashima, K. Misawa, K. Ikuta, A.L. Mui, and T. Kitamura. 1999. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18: 4754-4765.
36. Oft, M., K.H. Heider, and H. Beug. 1998. TGFβ signalling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8: 1243-1252.
37. Okajima, Y., I. Matsumura, T. Nishiura, K. Hashimoto, H. Yoshida, J. Ishikawa, H. Wakao, A. Yoshimura, Y. Kanakura, Y. Tomiyama, and Y. Matsuzawa. 1998. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J. Biol. Chem. 273: 22877-22883.
38. L by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes & Dev. 12: 2475-2487.
39. Persons, D.A., J.A. Allay, E.R. Allay, R.J. Smeyne, R.A. Ashmun, B.P. Sorrentino, and A.W. Nienhuis. 1997. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90: 1777-1786.
40. Persons, D.A., M.G. Mehaffey, M. Kaleko, A.W. Nienhuis, and E.F. Vanin. 1998. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24: 167-182.
41. Quelle, F.W., D. Wang, T. Nosaka, W.E. Thierfelder, D. Stravopodis, Y. Weinstein, and J.N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622-1631.
42. Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387: 773-776.
43. Silva, M., A. Benito, C. Sanz, F. Prosper, D. Ekhterae, G. Nuñez, and J.L. Fernandez-Luna. 1999. Erythropoietin can induce the expression of Bcl-xL through Stat5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem. 274:22165-22169.
44. Stanley, E., G.J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J.A. Gall, D.W. Maher, J. Cebon, V. Sinickas, and A.R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. 91: 5592-5596.
45. Stinnett, J.D. and J.A. Majeski. 1980. Macrophage activation and mobilization in nude mice by Corynebacterium parvum and pyran: A functional and histologic study. J. Surg. Oncol. 14: 327-332.
46. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161: 4652-4660.
47. Teglund, S., C. McKay, E. Schuetz, J.M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J.N. Ihle. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850.
48. Tran Quang, C., O. Wessely, M. Pironin, H. Beug, and J. Ghysdael. 1997. Cooperation of SPI-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and EPO-dependent differentiation in primary erythroblasts and induces their KIT-ligand dependent proliferation. EMBO J. 16: 5639-5653.
49. Wakao, H., F. Gouilleux, and B. Groner. 1994. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response EMBO J. 1994, May 13(9): 2182-2191. [Published erratum appeared in EMBO J.1995 Feb. 15 14(4): 854-855.]
50. Weining, K.C., U. Schultz, U. Munster, B. Kaspers, and P. Staeheli. 1996. Biological properties of recombinant chicken interferon-gamma. Eur. J. Immunol. 26: 2440-2447.
51. Wessely, O., A. Bauer, C.T. Quang, E.M. Deiner, M. von Lindern, G. Mellitzer, P. Steinlein, J. Ghysdael, and H. Beug. 1999. A novel way to induce erythroid progenitor self renewal: Cooperation of c-Kit with the erythropoietin receptor. Biol. Chem. 380: 187-202.
52. Woldman, I., G. Mellitzer, M. Kieslinger, D. Buchhart, A. Meinke, H. Beug, and T. Decker. 1997. Stat5 involvement in the differentiation response of primary chicken myeloid progenitor cells to chicken myelomonocytic growth factor. J. Immunol. 159: 877-886.
53. Yoshimura, A. 1998. The CIS family: Negative regulators of JAK-STAT signaling. Cytokine Growth Factor Rev. 9: 197-204.
54. Zamorano, J., H.Y. Wang, R. Wang, Y. Shi, G.D. Longmore, and A.D. Keegan. 1998. Regulation of cell growth by IL-2: Role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol. 160:3502-3512.
55. Zhang, G., V. Gurtu, S.R. Kain, and G. Yan. 1997. Early detection of apoptosis using a fluorescent conjugate of Annexin V. BioTechniques 23: 525-531.